Cargando…
A novel RNA sequencing‐based miRNA signature predicts with recurrence and outcome of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the fifth most common type of cancer and the second leading cause of cancer‐related deaths worldwide. Given that the rate of HCC recurrence 5 years after liver resection is as high as 70%, patient with HCC typically has a poor outcome. A biomarker or set of biomarke...
Autores principales: | Bai, Fumao, Zhou, Huaibin, Ma, Mengni, Guan, Chen, Lyu, Jianxin, Meng, Qing H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026871/ https://www.ncbi.nlm.nih.gov/pubmed/29719937 http://dx.doi.org/10.1002/1878-0261.12315 |
Ejemplares similares
-
Metformin Inhibits Tumorigenesis and Tumor Growth of Breast Cancer Cells by Upregulating miR-200c but Downregulating AKT2 Expression
por: Zhang, Jiali, et al.
Publicado: (2017) -
Novel miRNA signature for predicting the stage of hepatocellular carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2020) -
Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma
por: Jin, Ze, et al.
Publicado: (2022) -
Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
por: Meng, Tongyu, et al.
Publicado: (2022) -
Evaluation of miRNA-7, miRNA-10 and miRNA-21 as diagnostic non-invasive biomarkers of hepatocellular carcinoma
por: Elabd, Walaa K., et al.
Publicado: (2023)